Fact CheckerSign in

NCT07751978Recruiting

Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs

Source: ClinicalTrials.gov · Last updated 8 Oct 2026

Brief summary (registry, in English)

The goal of this study is to test whether a program reduce stigma will help women living HIV remain in HIV care.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
4 Aug 2026
Start date
18 Sept 2026
Primary completion date
30 Sept 2027
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Diseases
HIV
NCT number
NCT07751978

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 18 Sept 2026 to the primary completion date, 30 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unable to provide informed consent due to intoxication, the effects of drug use, or severe psychiatric impairment at the time of consent.

Other

  • Does not meet the inclusion criteria;
  • Unable to provide informed consent;

Who the study is looking for

  • Female; Age 18 years or older;
  • Registered in the national Medical Information System (MIS) as having received an HIV-positive diagnosis;
  • Registered in the MIS with injection drug use (IDU) as the probable mode of HIV transmission or with a documented history of injection drug use at any clinical visit.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ukrainian Institute on Public Health Policy
Coordinator of this site? Confirm its status
KyivUkraineRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.